
Home / Clinics Supported / Neurological Wellness
TBI and concussion. PTSD. Stroke recovery. MS. Long COVID. A neurological wellness clinic gives these patients somewhere to turn, working alongside their existing care rather than replacing it.
Book a Strategy CallNo medical background is required to own the business. An independent, state-licensed Medical Director directs all clinical care.
Conventional medicine manages neurological conditions; it rarely gives the patient a sense of forward motion. The TBI patient told to rest and wait. The veteran with PTSD still looking for more. The long COVID patient whose brain fog has outlasted every explanation. The Defense Department alone counts 535,544 service members diagnosed with traumatic brain injury from 2000 through 2025.
When they find a clinic that takes them seriously and is straight about what the evidence does and does not show, they can become long-term patients who bring others. Our clinic launch consulting helps you open that clinic, with no franchise fees or royalties.
Many owners in this category have a personal connection: a son with a brain injury, a parent after a stroke, a friend who came home from deployment changed. Told authentically, that story is one of the most powerful marketing assets a neurological wellness clinic has.
Traumatic brain injury and concussion patients
Veterans living with TBI and PTSD
Stroke survivors in recovery
People living with MS
People living with Parkinson's disease
Neuropathy and peripheral nerve patients
Long COVID and persistent brain fog
Adults managing chronic stress and anxiety
Athletes and adults focused on cognitive longevity
Describes the patient populations these clinics attract. Clinical decisions for any individual rest with the Medical Director.
HBOT, NAD+ infusion, neurofeedback and photobiomodulation, under real medical oversight.
The anchor modality. HBOT has a defined set of FDA-cleared indications; its neurological uses are off-label and physician-directed, and a 2018 Department of Veterans Affairs evidence review found the evidence on TBI and PTSD inconclusive.
Intravenous NAD+ protocols: a premium session line and a natural pairing with HBOT packages. See IV Therapy & Infusion for the standalone model.
EEG neurofeedback sessions, a recurring session line. FDA classes them as biofeedback devices, and the exemption from premarket review covers prescription devices for relaxation training and muscle reeducation; claims beyond that need a device cleared for them.
Photobiomodulation and pulsed electromagnetic field sessions: non-invasive, low-overhead recurring lines. Device selection, within each device's FDA-cleared uses, is a Medical Director decision.
Which cellular products a clinic can lawfully offer turns on FDA's 361 vs 351 rules, and treatment claims draw enforcement: in 2018 the FTC settled with a clinic group that advertised stem cell therapy for Parkinson's disease and autism. See the stem cell clinic model first.
Patients ask about Selank, Semax and BPC-157 by name. Selank cannot be lawfully compounded today (October 2026), and Semax and BPC-157 rest on a temporary HHS enforcement discretion policy (October 2026), not a listing or an approval. See Peptide Therapy for the status table.
Many patients who walk into a neurological wellness clinic have been let down twice: by a system that offered management and little else, and by a clinic that promised a cure and handed them a bill. That second letdown is why this category draws regulatory attention, and why these patients find it hard to know who to trust.
The clinic that wins here refuses to be the second disappointment. It is the more defensible business, because trust is what this patient struggles to find anywhere else.
The clinic complements the patient's existing medical care. The FDA's central concern about HBOT is patients delaying or forgoing proven therapy, so the clinic that coordinates with a neurologist is both the safer one and the more trusted one.
Neurological uses of HBOT are off-label and the research is emerging rather than settled. Patients who have heard every promise respond to the clinic that says so plainly and sets real expectations.
Assessments at intake and follow-up turn a hope into a record, and into the evidence base your clinic builds for itself.
Neurological wellness clinics have specific requirements: HBOT safety and chamber operations, off-label informed consent, Medical Director oversight, and marketing that is compelling without making claims the category cannot support.
FDA recommends HBOT under a doctor's care in a hospital or facility with hyperbaric accreditation. ACG helps clinics build their HBOT operation toward the Undersea and Hyperbaric Medical Society's standards, a credibility signal patients and referring physicians both recognize.
Identify which patient populations have the highest unmet need in your market: veterans, concussion, stroke recovery, long COVID.
Off-label informed consent, patient screening, and an independent, state-licensed Medical Director who directs all clinical care.
Chamber sourcing, installation, safety protocols, and operational setup built toward UHMS standards, at preferred pricing through ACG's vendor network.
Intake and follow-up assessments built into the protocol from day one.
SEO strategy, veteran service organization partnerships, and referral relationships with neurologists and rehab providers, built around the patients you serve. Marketing execution is a separate engagement.
Straight answers on HBOT, which conditions a clinic can market for, equipment and working alongside neurologists. Anything else, ask on the strategy call.
View All FAQs
Be the clinic that deserves their trust. Talk with Grayson Miller about the patients in your market, the HBOT and compliance picture and what opening takes. No pitch. No obligation.
ACG is a consulting and advisory firm, not a medical practice; an independent, state-licensed Medical Director directs all clinical care. Results are not guarantees of income. Individual outcomes vary. The 60-day target begins from clinic keys received, market and regulatory conditions permitting.
Knowing the rules is the foundation of every clinic we help launch.
You own and run the business. An independent, state-licensed Medical Director makes every clinical, prescribing and treatment decision, structured for your state's Corporate Practice of Medicine laws. We connect you to a vetted network; you retain your own provider.
PRP, peptides, GLP-1 medications and cellular products each carry federal and state rules, and not every product or use is FDA-approved. Exosomes for therapeutic use are not FDA-approved at all, and we steer you away from them. Your menu and marketing are built to hold up to FDA, FTC and state medical board scrutiny.
We show real ranges and never promise an income or a clinical outcome. What you earn depends on your market, your capital and your execution.
Altos Consulting Group is a business consulting and advisory firm, not a medical practice, and does not provide, prescribe or sell any drug, biologic, device or therapy. The FDA has stated there are currently no FDA-approved exosome products for the treatment of any disease; clinic owners are responsible for the compliance of every product, therapy and claim. See the full regulatory notice below.